Literature DB >> 25337223

B-myb is a gene implicated in cell cycle and proliferation of breast cancer.

Deyou Tao1, Yihong Pan2, Hongsheng Lu3, Song Zheng4, Hui Lin5, Hongyan Fang1, Feilin Cao5.   

Abstract

B-myb belongs to the myb family of transcription factors that include A-myb and c-myb. While A-myb and c-myb are tissue-specific, B-myb is broadly expressed in rapidly dividing cells of developing adult mammals. Results of our study showed that increased B-myb expression of was associated with the progression of breast cancer and that B-myb protein levels were significantly elevated in matched metastases. High B-myb levels also predict shorter overall survival of breast cancer patients. Moreover, B-myb stimulated transcription of target genes that promoted entry into the S and M-phases of the cell cycle, cell proliferation, migration and invasion in breast cancer. Taken together, our results strongly demonstrated that B-myb had a critical role in both cell cycle progression and tumorigenesis, and might serve as a novel potential target in the diagnosis and/or treatment of human breast cancer.

Entities:  

Keywords:  B-myb; breast cancer; cell cycle; invasion; migration; proliferation

Mesh:

Substances:

Year:  2014        PMID: 25337223      PMCID: PMC4203194     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  19 in total

1.  Regulation of B-Myb activity by cyclin D1.

Authors:  S Horstmann; S Ferrari; K H Klempnauer
Journal:  Oncogene       Date:  2000-01-13       Impact factor: 9.867

Review 2.  B-Myb protein in cellular proliferation, transcription control, and cancer: latest developments.

Authors:  A Sala; R Watson
Journal:  J Cell Physiol       Date:  1999-06       Impact factor: 6.384

3.  Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft.

Authors:  Anat Bar-Shira; Jehonathan H Pinthus; Uri Rozovsky; Myriam Goldstein; William R Sellers; Yuval Yaron; Zelig Eshhar; Avi Orr-Urtreger
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

Review 4.  Cell cycle regulation by the B-Myb transcription factor.

Authors:  M Joaquin; R J Watson
Journal:  Cell Mol Life Sci       Date:  2003-11       Impact factor: 9.261

5.  B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines.

Authors:  M Arsura; M Introna; F Passerini; A Mantovani; J Golay
Journal:  Blood       Date:  1992-05-15       Impact factor: 22.113

6.  Cell-cycle regulation of human B-myb transcription.

Authors:  E W Lam; J D Bennett; R J Watson
Journal:  Gene       Date:  1995-07-28       Impact factor: 3.688

7.  Isolation of human cDNA clones of myb-related genes, A-myb and B-myb.

Authors:  N Nomura; M Takahashi; M Matsui; S Ishii; T Date; S Sasamoto; R Ishizaki
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

8.  Cyclin D1-dependent regulation of B-myb activity in early stages of neuroblastoma differentiation.

Authors:  V Cesi; B Tanno; R Vitali; C Mancini; M L Giuffrida; B Calabretta; G Raschellà
Journal:  Cell Death Differ       Date:  2002-11       Impact factor: 15.828

9.  The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain.

Authors:  Manel Joaquin; Roger J Watson
Journal:  J Biol Chem       Date:  2003-08-28       Impact factor: 5.157

10.  Characterization and cell cycle-regulated expression of mouse B-myb.

Authors:  E W Lam; C Robinson; R J Watson
Journal:  Oncogene       Date:  1992-09       Impact factor: 9.867

View more
  9 in total

1.  MELK as a potential target to control cell proliferation in triple-negative breast cancer MDA-MB-231 cells.

Authors:  Gang Li; Mei Yang; Li Zuo; Mei-Xing Wang
Journal:  Oncol Lett       Date:  2018-04-20       Impact factor: 2.967

2.  The role of MYB proto-oncogene like 2 in tamoxifen resistance in breast cancer.

Authors:  Xia Li; Xi Zhang; Cong-Cong Wu; Ping-Ping Li; Yi-Mou Fu; Li-Hua Xie; Shuang-Shuang Sun; Ying-Ying Zhou; Bao-Ling Zhu
Journal:  J Mol Histol       Date:  2020-11-03       Impact factor: 2.611

3.  The Short Isoform of Nuclear Mitotic Apparatus Protein 1 Functions as a Putative Tumor Suppressor.

Authors:  Wang-Sen Qin; Jin Wu; Yang Chen; Fa-Cai Cui; Fu-Ming Zhang; Guan-Ting Lyu; Hong-Mei Zhang
Journal:  Chin Med J (Engl)       Date:  2017-08-05       Impact factor: 2.628

Review 4.  MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis.

Authors:  Julian Musa; Marie-Ming Aynaud; Olivier Mirabeau; Olivier Delattre; Thomas Gp Grünewald
Journal:  Cell Death Dis       Date:  2017-06-22       Impact factor: 8.469

Review 5.  Association between B-Myb proto-oncogene and the development of malignant tumors.

Authors:  Yuelei Jin; Gangqiao Qi; Guang Chen; Chen Wang; Xiaoyan Fan
Journal:  Oncol Lett       Date:  2021-01-04       Impact factor: 2.967

6.  Circulating Exosomal microRNAs as Predictive Biomarkers of Neoadjuvant Chemotherapy Response in Breast Cancer.

Authors:  Valentina K Todorova; Stephanie D Byrum; Allen J Gies; Cade Haynie; Hunter Smith; Nathan S Reyna; Issam Makhoul
Journal:  Curr Oncol       Date:  2022-01-28       Impact factor: 3.677

7.  Actin-binding Rho activating C-terminal like (ABRACL) transcriptionally regulated by MYB proto-oncogene like 2 (MYBL2) promotes the proliferation, invasion, migration and epithelial-mesenchymal transition of breast cancer cells.

Authors:  Jie Li; Hui Chen
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 8.  Novel Molecular Markers for Breast Cancer.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Biomark Cancer       Date:  2016-03-13

9.  B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.

Authors:  Xiaoyan Fan; Yitao Wang; Tinghui Jiang; Wei Cai; Yuelei Jin; Yulong Niu; Huifang Zhu; Youquan Bu
Journal:  Int J Mol Sci       Date:  2018-05-16       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.